The Valley Desk

NCT04048135 · Interventional trial

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

Overall registry status Completed

Phase 1 · Phase 2

Conditions NASH

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov